Vaccinex, Inc. Files 8-K Report
Ticker: VCNX · Form: 8-K · Filed: Jul 31, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
VACCINEX files 8-K, mostly procedural stuff, no major news yet.
AI Summary
On July 31, 2024, Vaccinex, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and headquartered in Rochester, NY.
Why It Matters
This 8-K filing indicates that Vaccinex, Inc. has submitted required regulatory documentation, though the specific details of 'Other Events' are not elaborated in this excerpt.
Risk Assessment
Risk Level: low — The provided text is a standard regulatory filing notification without any disclosed material events or financial performance data.
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- July 31, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Rochester, New York (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Vaccinex, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of July 31, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 31, 2024.
Where is Vaccinex, Inc. incorporated?
Vaccinex, Inc. is incorporated in Delaware.
What is the principal executive office address for Vaccinex, Inc.?
The principal executive office address for Vaccinex, Inc. is 1895 Mount Hope Avenue, Rochester, New York 14620.
What is the IRS Employer Identification Number for Vaccinex, Inc.?
The IRS Employer Identification Number for Vaccinex, Inc. is 16-1603202.
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-07-31 09:05:29
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
Filing Documents
- d858316d8k.htm (8-K) — 25KB
- d858316dex991.htm (EX-99.1) — 18KB
- g858316g0731020058828.jpg (GRAPHIC) — 3KB
- 0001193125-24-189569.txt ( ) — 170KB
- vcnx-20240731.xsd (EX-101.SCH) — 3KB
- vcnx-20240731_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240731_pre.xml (EX-101.PRE) — 11KB
- d858316d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated July 31, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VACCINEX, INC. Date: July 31, 2024 By: /s/ Jill Sanchez Jill Sanchez Chief Financial Officer